Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to HK$1.65, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 6x in the Insurance industry in Hong Kong. Total returns to shareholders of 36% over the past three years. Announcement • Jun 01
Yunfeng Financial Group Limited, Annual General Meeting, Jun 26, 2026 Yunfeng Financial Group Limited, Annual General Meeting, Jun 26, 2026, at 15:00 China Standard Time. Reported Earnings • Apr 29
Full year 2025 earnings released: EPS: HK$0.17 (vs HK$0.12 in FY 2024) Full year 2025 results: EPS: HK$0.17 (up from HK$0.12 in FY 2024). Revenue: HK$4.19b (up 13% from FY 2024). Net income: HK$652.6m (up 39% from FY 2024). Profit margin: 16% (up from 13% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 27
Full year 2025 earnings released: EPS: HK$0.17 (vs HK$0.12 in FY 2024) Full year 2025 results: EPS: HK$0.17 (up from HK$0.12 in FY 2024). Revenue: HK$4.24b (up 15% from FY 2024). Net income: HK$652.6m (up 39% from FY 2024). Profit margin: 15% (up from 13% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 33% per year, which means it is significantly lagging earnings growth. New Risk • Mar 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 9.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 0.7% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.8% average weekly change). Valuation Update With 7 Day Price Move • Mar 16
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to HK$3.24, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 9x in the Insurance industry in Hong Kong. Total returns to shareholders of 170% over the past three years. Announcement • Mar 12
Yunfeng Financial Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026 Yunfeng Financial Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026 Valuation Update With 7 Day Price Move • Oct 06
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to HK$6.51, the stock trades at a trailing P/E ratio of 34.9x. Average trailing P/E is 8x in the Insurance industry in Hong Kong. Total returns to shareholders of 623% over the past three years. Valuation Update With 7 Day Price Move • Sep 22
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to HK$6.12, the stock trades at a trailing P/E ratio of 31.3x. Average trailing P/E is 8x in the Insurance industry in Hong Kong. Total returns to shareholders of 477% over the past three years. Announcement • Sep 16
Yunfeng Financial Group Limited has filed a Follow-on Equity Offering in the amount of HKD 1.16693 billion. Yunfeng Financial Group Limited has filed a Follow-on Equity Offering in the amount of HKD 1.16693 billion.
Security Name: Ordinary Share
Security Type: Common Stock
Securities Offered: 191,300,000
Price\Range: HKD 6.1
Transaction Features: Subsequent Direct Listing Valuation Update With 7 Day Price Move • Sep 05
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to HK$3.92, the stock trades at a trailing P/E ratio of 20x. Average trailing P/E is 8x in the Insurance industry in Hong Kong. Total returns to shareholders of 229% over the past three years. Reported Earnings • Aug 31
First half 2025 earnings released: EPS: HK$0.13 (vs HK$0.052 in 1H 2024) First half 2025 results: EPS: HK$0.13 (up from HK$0.052 in 1H 2024). Revenue: HK$2.26b (up 30% from 1H 2024). Net income: HK$486.5m (up 142% from 1H 2024). Profit margin: 22% (up from 12% in 1H 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Announcement • Aug 18
Yunfeng Financial Group Limited to Report First Half, 2025 Results on Aug 28, 2025 Yunfeng Financial Group Limited announced that they will report first half, 2025 results on Aug 28, 2025 Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to HK$3.70, the stock trades at a trailing P/E ratio of 30.4x. Average trailing P/E is 10x in the Insurance industry in Hong Kong. Total returns to shareholders of 168% over the past three years. Valuation Update With 7 Day Price Move • Jul 08
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to HK$3.00, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 10x in the Insurance industry in Hong Kong. Total returns to shareholders of 103% over the past three years. Valuation Update With 7 Day Price Move • Jun 13
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to HK$2.27, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 8x in the Insurance industry in Hong Kong. Total returns to shareholders of 63% over the past three years. Announcement • Jun 03
Yunfeng Financial Group Limited, Annual General Meeting, Jun 27, 2025 Yunfeng Financial Group Limited, Annual General Meeting, Jun 27, 2025, at 15:00 China Standard Time. Location: 5/f, yf life centre, 38 gloucester road, wanchai, Hong Kong Valuation Update With 7 Day Price Move • May 02
Investor sentiment improves as stock rises 36% After last week's 36% share price gain to HK$1.28, the stock trades at a trailing P/E ratio of 10.5x. Average trailing P/E is 8x in the Insurance industry in Hong Kong. Total loss to shareholders of 6.6% over the past three years. New Risk • Apr 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 19% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings have declined by 11% per year over the past 5 years. Reported Earnings • Mar 30
Full year 2024 earnings released: EPS: HK$0.12 (vs HK$0.10 in FY 2023) Full year 2024 results: EPS: HK$0.12 (up from HK$0.10 in FY 2023). Revenue: HK$3.69b (up 5.2% from FY 2023). Net income: HK$470.8m (up 19% from FY 2023). Profit margin: 13% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Announcement • Mar 14
Yunfeng Financial Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025 Yunfeng Financial Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025 Valuation Update With 7 Day Price Move • Oct 03
Investor sentiment improves as stock rises 43% After last week's 43% share price gain to HK$1.30, the stock trades at a trailing P/E ratio of 10.9x. Average trailing P/E is 9x in the Insurance industry in Hong Kong. Total loss to shareholders of 39% over the past three years. Reported Earnings • Sep 28
First half 2024 earnings released: EPS: HK$0.052 (vs HK$0.036 in 1H 2023) First half 2024 results: EPS: HK$0.052 (up from HK$0.036 in 1H 2023). Revenue: HK$1.74b (up 6.9% from 1H 2023). Net income: HK$201.0m (up 46% from 1H 2023). Profit margin: 12% (up from 8.5% in 1H 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 20% per year whereas the company’s share price has fallen by 24% per year. New Risk • Aug 30
New major risk - Revenue and earnings growth Earnings have declined by 9.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Announcement • Aug 22
Yunfeng Financial Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2024 Yunfeng Financial Group Limited provided consolidated earnings guidance for the six months ended 30 June 2024. For the six months, the Group is expected to record a net profit attributable to the equity shareholders of the Company for 2024 Interim Period of approximately HKD 200 million, which represents an increase of approximately 45% compared to the net profit attributable to equity shareholders of approximately HKD 138 million for the six months ended 30 June 2023. The increase in the net profit of the Group for 2024 Interim Period is mainly due to the benefit of the improvement of the Group's overall operating performance and the receipt of a one-off financial incentive offered by the Mandatory Provident Fund Schemes Authority to the first trustee to get onboard the eMPF Platform (an electronic MPF administration and management platform). Announcement • Aug 20
Yunfeng Financial Group Limited to Report First Half, 2024 Results on Aug 29, 2024 Yunfeng Financial Group Limited announced that they will report first half, 2024 results on Aug 29, 2024 Reported Earnings • Mar 28
Full year 2023 earnings released: EPS: HK$0.10 (vs HK$0.067 loss in FY 2022) Full year 2023 results: EPS: HK$0.10 (up from HK$0.067 loss in FY 2022). Revenue: HK$5.78b (down 36% from FY 2022). Net income: HK$397.2m (up HK$653.6m from FY 2022). Profit margin: 6.9% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 37% per year, which means it has not declined as severely as earnings. Announcement • Mar 13
Yunfeng Financial Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024 Yunfeng Financial Group Limited announced that they will report fiscal year 2023 results on Mar 27, 2024 Buy Or Sell Opportunity • Mar 05
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 4.7% to HK$0.82. The fair value is estimated to be HK$1.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Meanwhile, the company has become profitable. Buy Or Sell Opportunity • Feb 14
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to HK$0.80. The fair value is estimated to be HK$1.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Jan 17
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be HK$1.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Sep 01
First half 2023 earnings released: EPS: HK$0.036 (vs HK$0.052 loss in 1H 2022) First half 2023 results: EPS: HK$0.036 (up from HK$0.052 loss in 1H 2022). Revenue: HK$2.72b (down 24% from 1H 2022). Net income: HK$137.9m (up HK$336.5m from 1H 2022). Profit margin: 5.1% (up from net loss in 1H 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings. Announcement • Aug 24
Yunfeng Financial Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 Yunfeng Financial Group Limited provided consolidated earnings guidance for the six months ended June 30, 2023. For the six months, the group is expected to record a net profit attributable to the equity shareholders of the Company for 2023 Interim Period of approximately HKD 130 million. After restatement based on the New Standard, a net loss attributable to equity shareholders of approximately HKD 482 million is expected to have been recorded for the six months ended 30 June 2022 (the "2022 Interim Period"). Based on the Old Standard, the net loss attributable to equity shareholders recorded for 2022 Interim Period was approximately HKD 199 million. The expected turnaround for 2023 Interim Period is mainly due to the fair value loss of the Group's investments having significantly decreased as compared to the same period last year. The difference between the loss for 2022 Interim Period under the New Standard and the Old Standard is mainly due to the fact that under the New Standard, the changes in the fair value of certain bonds and equity investments held by the Company's principal subsidiary, YF Life Insurance International Limited, are required to be recognized in the income statement, whereas under the Old Standard, such fair value changes were recognized in the fair value reserve. Announcement • Aug 19
Yunfeng Financial Group Limited to Report First Half, 2023 Results on Aug 30, 2023 Yunfeng Financial Group Limited announced that they will report first half, 2023 results on Aug 30, 2023 Announcement • Jul 01
Yunfeng Financial Group Limited Announces the Resignation of Adnan Omar Ahmed as Non-Executive Director The board of directors of Yunfeng Financial Group Limited announced that Mr. Adnan Omar Ahmed has tendered his resignation from the position of non- executive director of the Company with effect from 30 June 2023 due to his departure from substantial shareholder of the Company, MassMutual International LLC, which he represented. Announcement • May 25
Yunfeng Financial Group Limited, Annual General Meeting, Jun 16, 2023 Yunfeng Financial Group Limited, Annual General Meeting, Jun 16, 2023, at 15:00 China Standard Time. Location: 5/F, China Evergrande Centre, 38 Gloucester Road Wanchai Hong Kong Agenda: To receive, consider and adopt the audited Financial Statements, the Report of the Directors and the Independent Auditor's Report for the year ended 31 December 2022; to re-elect Ms. Hai Olivia Ou as a non-executive director; to re-elect Mr. Qi Daqing as an independent non-executive director; to re-elect Mr. Chu Chung Yue, Howard as an independent non-executive director; to authorize the board of Directors to fix the Directors' remuneration; to re-appoint KPMG as the independent auditor of the Company and to authorize the Board to fix their remuneration; and to consider other matters. Reported Earnings • Mar 31
Full year 2022 earnings released: HK$0.067 loss per share (vs HK$0.13 profit in FY 2021) Full year 2022 results: HK$0.067 loss per share (down from HK$0.13 profit in FY 2021). Revenue: HK$8.96b (down 15% from FY 2021). Net loss: HK$256.4m (down 150% from profit in FY 2021). Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. Buying Opportunity • Nov 18
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 28%. The fair value is estimated to be HK$1.22, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Meanwhile, the company became loss making. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Non-executive Director Feng Xiao was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Buying Opportunity • Aug 12
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 9.9%. The fair value is estimated to be HK$1.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 43% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Apr 27
Full year 2021 earnings released: EPS: HK$0.13 (vs HK$0.19 in FY 2020) Full year 2021 results: EPS: HK$0.13 (down from HK$0.19 in FY 2020). Revenue: HK$10.6b (down 1.1% from FY 2020). Net income: HK$513.4m (down 17% from FY 2020). Profit margin: 4.9% (down from 5.8% in FY 2020). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 35% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Non-executive Director Feng Xiao was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 28
Full year 2021 earnings released: EPS: HK$0.13 (vs HK$0.19 in FY 2020) Full year 2021 results: EPS: HK$0.13 (down from HK$0.19 in FY 2020). Revenue: HK$10.6b (down 1.1% from FY 2020). Net income: HK$513.4m (down 17% from FY 2020). Profit margin: 4.9% (down from 5.8% in FY 2020). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 33% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improved over the past week After last week's 23% share price gain to HK$1.57, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 5x in the Insurance industry in Hong Kong. Total loss to shareholders of 68% over the past three years. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 16% share price gain to HK$1.72, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 5x in the Insurance industry in Hong Kong. Total loss to shareholders of 63% over the past three years. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment deteriorated over the past week After last week's 18% share price decline to HK$1.36, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 5x in the Insurance industry in Hong Kong. Total loss to shareholders of 70% over the past three years. Reported Earnings • Aug 30
First half 2021 earnings released: EPS HK$0.12 (vs HK$0.034 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: HK$5.15b (up 66% from 1H 2020). Net income: HK$459.5m (up 321% from 1H 2020). Profit margin: 8.9% (up from 3.5% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 110% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Aug 25
Investor sentiment improved over the past week After last week's 17% share price gain to HK$2.46, the stock trades at a trailing P/E ratio of 13.2x. Average trailing P/E is 6x in the Insurance industry in Hong Kong. Total loss to shareholders of 47% over the past three years. Reported Earnings • Apr 18
Full year 2020 earnings released: EPS HK$0.19 (vs HK$0.08 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: HK$10.7b (up 29% from FY 2019). Net income: HK$618.3m (up 142% from FY 2019). Profit margin: 5.8% (up from 3.1% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 28
Full year 2020 earnings released: EPS HK$0.19 (vs HK$0.08 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: HK$10.7b (up 29% from FY 2019). Net income: HK$618.3m (up 142% from FY 2019). Profit margin: 5.8% (up from 3.1% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Mar 05
New 90-day low: HK$2.87 The company is down 12% from its price of HK$3.27 on 04 December 2020. The Hong Kong market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 2.0% over the same period. Is New 90 Day High Low • Dec 25
New 90-day low: HK$2.96 The company is down 21% from its price of HK$3.76 on 25 September 2020. The Hong Kong market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 9.0% over the same period. Is New 90 Day High Low • Dec 07
New 90-day low: HK$3.21 The company is down 22% from its price of HK$4.11 on 08 September 2020. The Hong Kong market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 9.0% over the same period. Is New 90 Day High Low • Nov 11
New 90-day low: HK$3.30 The company is down 4.0% from its price of HK$3.44 on 13 August 2020. The Hong Kong market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 2.0% over the same period. Is New 90 Day High Low • Oct 09
New 90-day high: HK$4.18 The company is up 19% from its price of HK$3.51 on 10 July 2020. The Hong Kong market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is down 6.0% over the same period. 